Written and maintained by CASRAI Editorial Board
Last updated
This guide provides an informational overview of clinical software, imaging workflows, and regulatory standards. It does not provide medical advice or individual patient diagnostic instructions.
Short answer
Radiology artificial intelligence refers to computer vision and machine learning algorithms trained to acquire, optimize, analyze, and triage diagnostic medical images. Rather than replacing medical specialists, these software tools function as clinical decision support. They detect anomalies, measure anatomical structures, prioritize emergent cases, and export structured findings into imaging networks under human physician supervision.
Definition and scope
Radiology artificial intelligence (AI) encompasses software algorithms—predominantly deep neural networks—trained to process diagnostic images across modalities including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Its clinical scope spans the imaging life cycle from scan acquisition through post-scan interpretation.
In clinical workflows, image files conform to the Digital Imaging and Communications in Medicine standard. When an imaging study completes, AI software reads the series, extracts features, and generates quantitative outputs such as bounding boxes around suspicious findings, lesion segmentations, or prioritized worklist flags. Under consensus statements from professional imaging societies, clinical AI operates as an assistive technology: licensed radiologists retain sole diagnostic responsibility for interpreting findings and signing the final report.
How it works or how it is used in practice
The practical implementation of radiology artificial intelligence follows an operational pipeline within healthcare imaging environments:
- Image Acquisition Guidance: Before reconstruction, acquisition guidance algorithms evaluate patient positioning. Under FDA regulation 21 CFR 892.2100, AI-guided systems assist technologists in centering the patient, reducing motion artifacts, and optimizing radiation dose protocols.
- Data Ingestion and Preprocessing: Once images are captured, they are transmitted to a vendor neutral archive (VNA) or Picture Archiving and Communication System (PACS). An integration gateway routes the series to an inference engine. The software normalizes pixel intensities, resamples slice thicknesses, and checks protocol metadata against a DICOM conformance statement.
- Algorithmic Inference: Deep learning models perform inference tailored to clinical indications. In acute protocols, triage algorithms evaluate non-contrast head CTs or CT pulmonary angiograms within minutes, identifying large-vessel occlusions or acute filling defects.
- Structured Reporting and Worklist Flagging: Inference results are packaged into DICOM Structured Reporting (SR) or Segmentation (SEG) objects. The algorithm sends prioritized alerts directly to the radiology information system (RIS) and PACS worklists, reordering queues so emergencies are reviewed ahead of routine studies.
- Clinician Review and Lifecycle Monitoring: Radiologists review AI findings alongside raw series, accepting or rejecting marks. Under Good Machine Learning Practice (GMLP) principles established by the FDA, Health Canada, and the UK MHRA, clinical sites monitor model performance continuously to identify data drift caused by scanner hardware or demographic shifts.
Types or related concepts
The U.S. Food and Drug Administration (FDA) classifies medical imaging algorithms as Software as a Medical Device (SaMD) under distinct regulatory controls in Title 21 of the Code of Federal Regulations (CFR):
| Regulatory Category | FDA Regulation & Code | Device Class | Core Functional Purpose | Clinician Decision Role |
|---|---|---|---|---|
| Computer-Assisted Triage and Notification (CADt) | 21 CFR 892.2080 (Product Code QAS) | Class II | Identifies time-sensitive findings and reprioritizes reading worklists for urgent review. | Aids triage only; clinician performs independent primary diagnostic interpretation. |
| Computer-Aided Detection (CADe) | 21 CFR 892.2050 (Product Code OEB, OMJ) | Class II | Marks suspicious regions or potential lesions on radiographs or CT scans to prevent perceptual omission. | Clinician reviews marked regions after primary review to verify whether lesions represent true pathology. |
| Computer-Assisted Diagnostic Software (CADx) | 21 CFR 892.2060 (Product Code POK) | Class II | Assists in characterizing previously detected lesions (e.g., estimating malignancy probability). | Provides quantitative characterization metrics; clinician determines final diagnosis. |
| Computer-Assisted Detection and Diagnosis (CADe/x) | 21 CFR 892.2090 (Product Code QDQ) | Class II | Combined detection, localization, and characterization of lesions suspicious for cancer or fractures. | Provides joint detection marks and diagnostic likelihood scores; primary decision remains with clinical user. |
| AI Image Acquisition and Optimization | 21 CFR 892.2100 (Product Code QJU) | Class II | Interfaces with hardware to guide operator positioning, reduce noise, and optimize radiation dose. | Guides technologist execution; diagnostic validity assessed during subsequent reading. |
Where it matters for labs, clinics or supply decisions
Integrating artificial intelligence into radiological operations directly impacts clinical facilities, clinical research facilities, and medical imaging procurement:
- Clinical Research and Validation Registries: In imaging research, standardized open repositories such as the Medical Imaging and Data Resource Center (MIDRC) provide multi-institutional imaging data for training and testing algorithms. Researchers evaluating AI applications follow rigorous AI reporting guidelines to prevent demographic bias and test generalizability across independent scanner cohorts.
- Acute Triage and Turnaround Times: In emergency departments, CADt software reduces notification delays for critical conditions like intracranial hemorrhage or pulmonary embolism, expediting care in time-critical windows.
- Infrastructure and Hardware Procurement: Deploying on-premises AI inference requires GPUs, secure edge gateways, and high-throughput network pipelines capable of transferring thin-slice datasets without latency. Clinic procurement teams must evaluate whether software licenses include model updates under FDA Predetermined Change Control Plans (PCCPs).
- Workflow Interoperability and Standards: Software applications must conform strictly to DICOM and Health Level Seven (HL7) standards to avoid communication bottlenecks between AI engines, VNAs, and electronic health record systems.
Common misunderstandings
Several frequent misconceptions surround the implementation of artificial intelligence in radiology:
- Myth 1: AI systems replace radiologists. Fact: Regulatory clearances designate radiology AI tools as decision support or triage software. The 2019 joint multisociety consensus statement from the ACR, RSNA, ESR, and CAR confirmed that diagnostic liability and patient care decisions remain exclusively with human clinicians.
- Myth 2: FDA 510(k) clearance guarantees superior accuracy across all settings. Fact: Most commercial AI tools obtain market clearance through the 510(k) pathway by demonstrating substantial equivalence to a predicate device. Clearance does not guarantee that an algorithm trained on one scanner manufacturer will perform identically across local patient populations without local site validation.
- Myth 3: CADt triage software makes primary diagnostic calls. Fact: Under 21 CFR 892.2080, triage software is cleared solely to alert and reorder worklists based on preliminary image analysis. It is neither intended nor cleared to substitute for a comprehensive physician review.
- Myth 4: Algorithm performance remains constant over time. Fact: Software algorithms are subject to model drift. Changes in scanner hardware, software reconstruction kernels, slice thickness protocols, or patient demographics can degrade accuracy, necessitating ongoing quality assurance.
Frequently asked questions
What is the difference between CADe, CADx, and CADt in radiology?
Computer-Aided Detection (CADe) marks suspicious regions to prevent perceptual oversight. Computer-Assisted Diagnosis (CADx) provides characterization metrics (such as probability of malignancy) for an already detected lesion. Computer-Assisted Triage and Notification (CADt) analyzes images in the background to identify acute emergencies and prioritize them in the review queue.
How does the FDA evaluate machine learning updates in radiology software?
Under the Good Machine Learning Practice (GMLP) framework and Predetermined Change Control Plans (PCCPs), manufacturers specify anticipated model modifications during premarket review. This mechanism allows controlled algorithmic updates without requiring an entirely new 510(k) submission for every iterative enhancement.
Who is legally responsible for a diagnostic error involving radiology AI?
The licensed interpreting physician retains legal and professional responsibility for the final diagnostic report. Clinical guidelines emphasize that AI tools serve solely as adjunctive decision support; radiologists must independently confirm or reject algorithmic prompts.
Why is local validation necessary before clinical deployment of radiology AI?
Local validation ensures an algorithm performs reliably on a hospital’s specific imaging equipment, slice thickness parameters, and patient demographic mix. Algorithms trained on external datasets can experience performance drops when exposed to novel clinical settings.
Sources
- U.S. Food and Drug Administration. Product Classification Database and Code of Federal Regulations Title 21 (Parts 892.2050, 892.2060, 892.2080, 892.2090, 892.2100). Accessed November 9, 2026. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm
- U.S. Food and Drug Administration, Health Canada, UK Medicines and Healthcare products Regulatory Agency. Good Machine Learning Practice for Medical Device Development: Guiding Principles. Published October 2021. Accessed November 9, 2026. https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles
- Geis, J. R., Brady, A. P., Wu, C. C., et al. Ethics of Artificial Intelligence in Radiology: Summary of the Joint European and North American Multisociety Statement. Radiology 2019; 293(2):436–440. Accessed November 9, 2026. https://pubs.rsna.org/doi/10.1148/radiol.2019191586
- National Electrical Manufacturers Association (NEMA) / DICOM Standards Committee. Digital Imaging and Communications in Medicine (DICOM) PS3.3 and PS3.16. Accessed November 9, 2026. https://www.dicomstandard.org/
